The Opioid Crisis Could Get Much Worse
According the NC Department of Health and Human Services, over 13,000 North Carolinians died between 1999 and 2017 from opioid overdoses - that’s nearly 2 deaths a day. In 2017 alone, there were 1,884 unintentional opioid overdose deaths. Based on our recent conversation with HHS Secretary Cohen, things have stopped getting worse - but they aren’t getting better.
Healthcare Heavyweights, Including Blue Cross NC, Talk Drug Prices in Washington
As rampant concern over rising drug costs continues to mount in Washington, yet another group is asking questions about what might be done to make medication more affordable for all Americans. The U.S. House Energy and Commerce Subcommittee on Health recently hosted 10 panelists to speak at a hearing it called, “Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain.”
Trump Unveils Ideas to End Surprise Bills, Calls on Congress
While reaching a consensus over health care seems increasingly harder these days in Washington, one priority both sides of the political aisle seem to agree on is stopping surprise billing. And President Donald Trump appears to be leading the charge.
Study Exposes Big Pharma’s Spending Habits
Research and development is the justification most commonly rattled off by Big Pharma when asked about rising drug prices. It takes money to investigate and develop these vitally needed drugs, they say. And while that part may be true, a recently released study found that drugmakers haven’t been entirely truthful with how they’re spending their money.
Lawsuit Alleging Coordinated Price Gouging Slapped Against 20 Pharma Companies
Price gouging, a coordinated attempt to hinder an investigation, destruction of evidence—no, this isn’t the plot of a summer blockbuster set to hit the big screen. It’s the reality of just the latest allegation against Big Pharma.
Republicans and Democrats Hope to Halt Drug Exclusivity
It seems like Big Pharma has a bag of tricks these days filled to the top with ideas and schemes to prevent drug prices from coming back down to Earth. Fortunately for American consumers, political heavyweights on both sides of the aisle are proposing ideas of their own to stop drugmakers’ attempts at stifling affordable medication.